WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Monday reported a loss of $13.5 million in its second quarter.
The Warren, New Jersey-based company said it had a loss of 14 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
The specialty pharmaceutical company posted revenue of $10 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $11.1 million.
In the final minutes of trading on Monday, the company’s shares hit $3.86. A year ago, they were trading at $3.43.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
